VMware has acquired one of its portfolio companies, app performance management platform Apteligent, in a deal that also gave exits to Alphabet, AOL and Accenture.

Cancer therapy developer G1 Therapeutics has gone public in an initial public offering that gave an exit to long-time investor MedImmune Ventures.

The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.

iRhythm Technologies, a developer of arrhythmia diagnostics technology spun out of Stanford University, has been awarded Exit of the Year by Global University Venturing.

Bruker has acquired Luxendo, a spinout of the European Molecular Biology Laboratory that closed an $8.4m series A round in January.

Yum China is set to purchase a majority stake in Daojia, an online food ordering platform that has raised some $75m from investors including JD.com.

The dark data processing technology developer, based on Stanford research, has been bought by Apple after raising about $20m from investors including In-Q-Tel.

The dark data processing technology developer has been bought by Apple after raising about $20m from investors including GV.

The machine learning-equipped online lender is exploring a flotation in the US that will allow Sunshine Insurance and Fosun to exit.